BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 10833617)

  • 1. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
    Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC
    J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower motor neuron syndrome associated with anti-GM1 antibodies.
    Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
    Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
    Willison HJ; Paterson G; Kennedy PG; Veitch J
    Ann Neurol; 1994 Apr; 35(4):471-8. PubMed ID: 8154875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies.
    Lardone RD; Alaniz ME; Irazoqui FJ; Nores GA
    J Neuroimmunol; 2006 Apr; 173(1-2):174-9. PubMed ID: 16376437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.